| NONCODE ID | SNP ID | GWAS trait | Source PMID |
| NONHSAG003198.3 | rs2840588 | Gene expression of PIGM in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs2840588 | Serum ratio of (2-tetradecenoyl carnitine)/(arabinose) | 21886157 |
| NONHSAG003198.3 | rs2840588 | Type 2 diabetes, combined control dataset | 17554300 |
| NONHSAG003198.3 | rs2840588 | Multiple complex diseases | 17554300 |
| NONHSAG003198.3 | rs7541727 | PROP taste detection threshold | 22132133 |
| NONHSAG003198.3 | rs7541727 | Response to cytadine analogues (cytosine arabinoside) | 24483146 |
| NONHSAG003198.3 | rs7541727 | Spine bone mineral density (BMD) | 18445777 |
| NONHSAG003198.3 | rs7541727 | AraC toxicity as measured by AraC IC50 in lymphoblastoid cell lines | 19898621 |
| NONHSAG003198.3 | rs7521490 | Stabilized warfarin dose | 18535201 |
| NONHSAG003198.3 | rs7521490 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs7521490 | Serum concentration of pyroglutamylglycine | 21886157 |
| NONHSAG003198.3 | rs7521490 | Autism | 20663923 |
| NONHSAG003198.3 | rs2840589 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs2820564 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs2820565 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs2820565 | Gene expression of PIGM [probe 2439944] in brain cortex | 19222302 |
| NONHSAG003198.3 | rs2840591 | Gene expression of SLAMF9 [probeset 1553770_a_at] in sputum | 21949713 |
| NONHSAG003198.3 | rs2840591 | Serum ratio of (glycerol 2-phosphate)/(glycerol 3-phosphate (G3P)) | 21886157 |
| NONHSAG003198.3 | rs2840591 | Spine bone mineral density (BMD) | 18445777 |
| NONHSAG003198.3 | rs2840591 | Tourette syndrome | 22889924 |
| NONHSAG003198.3 | rs2840591 | Tourette's syndrome | 22889924 |
| NONHSAG003198.3 | rs4378200 | Serum ratio of (3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF))/(lathosterol) | 21886157 |
| NONHSAG003198.3 | rs2789424 | Monocyte count | 21738479 |
| NONHSAG003198.3 | rs12748241 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs2789425 | Monocyte count | 21738479 |
| NONHSAG003198.3 | rs2789425 | Gene expression of SLAMF9 [probeset 1553770_a_at] in sputum | 21949713 |
| NONHSAG003198.3 | rs2789425 | Serum ratio of (glycerol 2-phosphate)/(glycerol 3-phosphate (G3P)) | 21886157 |
| NONHSAG003198.3 | rs2789425 | Spine bone mineral density (BMD) | 18445777 |
| NONHSAG003198.3 | rs4656862 | Serum ratio of (1-methylurate)/(octanoylcarnitine) | 21886157 |
| NONHSAG003198.3 | rs4656250 | Serum ratio of (7-methylxanthine)/(piperine) | 21886157 |
| NONHSAG003198.3 | rs2840592 | Adiponectin levels | 22479202 |
| NONHSAG003198.3 | rs2840592 | Serum concentration of 2-hydroxystearate | 21886157 |
| NONHSAG003198.3 | rs1317712 | Serum ratio of (1-stearoylglycerophosphoinositol)/(dodecanedioate) | 21886157 |
| NONHSAG003198.3 | rs1317712 | Multiple complex diseases | 17554300 |
| NONHSAG003198.3 | rs1317712 | Type 1 diabetes, Rheumatoid arthritis, combined case analysis | 17554300 |
| NONHSAG003198.3 | rs16831210 | Serum ratio of (octanoylcarnitine)/(sebacate (decanedioate)) | 21886157 |
| NONHSAG003198.3 | rs10908752 | Gene expression of GPR119 in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs10908752 | Serum ratio of (3-methyl-2-oxovalerate)/(4-methyl-2-oxopentanoate) | 21886157 |
| NONHSAG003198.3 | rs1317986 | Serum ratio of (caffeine)/(paraxanthine) | 21886157 |
| NONHSAG003198.3 | rs17375233 | Serum ratio of (heme*)/(lathosterol) | 21886157 |
| NONHSAG003198.3 | rs4656864 | Gene expression of MPPE1 in Temporal cortex | 20485568 |
| NONHSAG003198.3 | rs4656864 | Serum concentration of gamma-glutamylvaline | 21886157 |
| NONHSAG003198.3 | rs2494207 | Serum ratio of (pyroglutamylglycine)/(trigonelline (N'-methylnicotinate)) | 21886157 |
| NONHSAG003198.3 | rs7544170 | Serum ratio of (phenol sulfate)/(saccharin) | 21886157 |
| NONHSAG003198.3 | rs2494208 | Serum ratio of (arabinose)/(bradykinin, des-arg(9)) | 21886157 |
| NONHSAG003198.3 | rs2494208 | Gene expression of PIGM in normal prepouch ileum | 23474282 |
| NONHSAG003198.3 | rs2494208 | Multiple complex diseases | 17554300 |
| NONHSAG003198.3 | rs2494208 | Type 1 diabetes, Rheumatoid arthritis, combined case analysis | 17554300 |
| NONHSAG003198.3 | rs2494208 | Serum concentration of 1-linoleoylglycerol (1-monolinolein) | 21886157 |
| NONHSAG003198.3 | rs11809878 | Autism | 20663923 |
| NONHSAG003198.3 | rs11809878 | Gene expression of PIGM [probe 2439944] in peripheral blood mononuclear cells | 19222302 |
| NONHSAG003198.3 | rs2185214 | HIV-1 viral setpoint | 17641165 |
| NONHSAG003198.3 | rs2185214 | HIV-1 control (viral load at set point) | 17641165 |
| NONHSAG003198.3 | rs1934078 | Type 1 diabetes, Rheumatoid arthritis, combined case analysis, gender differentiated | 17554300 |
| NONHSAG003198.3 | rs1934078 | Multiple complex diseases | 17554300 |
| NONHSAG003198.3 | rs2211107 | Gene expression of AIF1 in lymphoblastoid cell lines | 17873877 |
| NONHSAG003198.3 | rs2211107 | Gene expression of PIGM in normal prepouch ileum | 23474282 |
| NONHSAG003198.3 | rs16831234 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs12135072 | Methylation levels at chr1:158268939-158268989 [hg18 coord, probe cg23004625] in Caudal pons | 20485568 |
| NONHSAG003198.3 | rs6678846 | Gene expression of PIGM in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs6678846 | Gene expression of HSPC152 in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs6678846 | Serum concentration of gamma-glutamylphenylalanine | 21886157 |
| NONHSAG003198.3 | rs12086013 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs7531304 | Gene expression of PIGM in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs7531304 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs12058277 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs6669066 | Gene expression of PIGM in normal prepouch ileum | 23474282 |
| NONHSAG003198.3 | rs2211108 | Serum ratio of (N2,N2-dimethylguanosine)/(quinate) | 21886157 |
| NONHSAG003198.3 | rs2211108 | Type 2 diabetes | 17463246 |
| NONHSAG003198.3 | rs2211108 | HOMA-IR | 17463246 |
| NONHSAG003198.3 | rs1934080 | Serum ratio of (allantoin)/(caffeine) | 21886157 |
| NONHSAG003198.3 | rs6427502 | Gene expression of PIGM in peripheral blood monocytes | 20502693 |
| NONHSAG003198.3 | rs6427502 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs12726002 | Nonsyndromic striae distensae (stretch marks) | 23633020 |
| NONHSAG003198.3 | rs12118914 | Gene expression of WDR42A [probe ILMN_11703] in untreated osteoblasts | 21283786 |
| NONHSAG003198.3 | rs12118914 | Serum ratio of (myo-inositol)/(pseudouridine) | 21886157 |
